Volume 22, No. 2                           June 1997



Warnings Issued at NFID-Sponsored Press Conference in Washington, DC

Recent Food-Borne Outbreaks and Antimicrobial Resistance are Increasing Global Threats

A contaminated food supply and life-threatening diseases caused by microbes resistant to antibiotics are predicted in the near future by health experts unless prevention measures are taken immediately. Microbial agents are not only infiltrating our food supply, living in our homes, and causing problems in hospitals, but they are becoming much more difficult to treat due to drug-resistant strains, according to health officials at a news conference this past April in Washington, DC, sponsored by the National Foundation for Infectious Diseases (NFID).

Michael T. Osterholm, PhD, MPH, the state epidemiologist for the Minnesota Department of Health, reported that recent food-borne outbreaks, such as the strawberry-associated hepatitis A outbreak, will only increase if steps are not taken to protect our food supply. "We believe that terminal pasteurization, including the use of irradiation, pulsed high-intensity light, increased atmospheric pressure treatment, or other such pathogen elimination methods, will be necessary on a wide-scale basis if we are to realize a safer food supply in the United States and throughout the world." He added that this is necessary "since food and vegetable washing does not appear to decrease the risk of infectious disease transmission."

Dr. Osterholm was one of several infectious disease experts speaking to approximately 35 journalists at the second Richard J. Duma/NFID Annual Press Conference on Infectious Diseases held on April 16, 1997 in Washington, DC. NFID holds the annual press conference, which was named to honor former NFID President and Executive Director Richard J. Duma, MD, PhD, to support its mission of educating the public about infectious diseases.

Speakers focused on such issues as food irradiation, flooding and toxigenic molds, drug-resistant pneumococcus, and antimicrobial resistance threats to hospitalized patients.

Dr. Osterholm continued his discussion of food-borne diseases by saying that consumers' dietary requirements and commercial sources for particular food products are other factors that affect our food supply. For example, the increased demand for fresh fruits and vegetables as part of a heart-healthy American diet has led to increased consumption of these items from foreign countries. "Seasonally, more than 75 percent of some fresh fruits and vegetables are harvested outside the United States, particularly in developing countries," Dr. Osterholm said. "These are the same fruits and vegetables that, when consumed in those developing countries, pose an increased risk of acquiring travelers' diarrhea." Improperly cooked domestic meats and other products also pose a health risk.

His view was echoed by Daniel L. Engeljohn, PhD, chief of the Standards Development Branch, Food Safety and Inspection Service with the US Department of Agriculture (USDA). Dr. Engeljohn added that it is important for irradiated food products to be properly labeled so that consumers can make educated food-purchasing decisions.

Joseph M. Madden, PhD, strategic manager for microbiology, Center for Food Safety and Applied Nutrition, US Food and Drug Administration (FDA), said that food irradiation has already been approved for limited uses, but the FDA is currently reviewing petitions for expanded uses.

Mold Cleanup After Flooding Recommended

Pulmonary hemorrhage among infants in Cleveland was associated with toxic molds in leaky basements, according to Ruth A. Etzel, MD, PhD. Dr. Etzel is a pediatrician and epidemiologist at the Centers for Disease Control and Prevention (CDC). In 1994, she led the team which made the discovery that infants in Cleveland with pulmonary hemorrhage, a life-threatening disease where infants cough up blood, were being exposed to toxigenic molds in their homes.

She discovered that the homes had suffered water damage as a result of flooding or plumbing problems which in turn promoted the growth of several molds, including the toxigenic Stachybotrys atra. This mold is known to cause heavy gastrointestinal bleeding in farm animals eating moldy grain. Infants in Cleveland may have been affected by breathing airborne mold spores.

Dr. Etzel said that appropriate mold cleanup should be emphasized following the recent flooding in the Midwest and Northwest. She suggests that any water-damaged items such as wet carpets should be replaced, and a bleach solution should be used to disinfect moldy areas to reduce the risks of toxigenic molds.

Drug-Resistant Pneumococcus Poses Health Threat

Streptococcus pneumoniae, commonly called pneumococcus, is the leading cause of community-acquired bacterial pneumonia, bloodstream infections, and ear infections, said Benjamin Schwartz, MD, chief of the Childhood and Vaccine Preventable Diseases Epidemiology Section at the CDC. This bacteria, which during the past decade has become resistant to many antibiotics, is posing a health threat, he added. "Pneumococcal infections cause about 20,000 deaths annually among persons of all ages in the United States and over one million deaths among children worldwide.

"In order to decrease, halt, or reverse the spread of pneumococcal resistance, we must decrease the unnecessary use of antibiotic agents," Dr. Schwartz added. To accomplish this goal, he suggests educating both the public and the medical establishment to these problems. Patients that expect to receive antibiotics for treatment and physicians that are unsure of the diagnosis are major reasons for antibiotic overuse, he said. "The paradigm must change from one where antibiotics are expected and prescribed just to be safe,' to one where the safest course of action is not providing an antibiotic unnecessarily."

Health Care Systems Must Address Antimicrobial Resistance

Antimicrobial resistance is also a growing problem for hospital patients, said John E. McGowan, Jr., MD, professor of epidemiology and pathology and medicine at Emory University in Atlanta. In the past, drug-resistant bacteria were mainly seen in hospital intensive care units. "Today, however, newly resistant organisms may appear at any location of the health system, and the distinction between hospital and community resistance is blurring," Dr. McGowan said.

To study this problem, Dr. McGowan serves as a co-director of Project ICARE (Intensive Care Antimicrobial Resistance Epidemiology), a joint project between CDC and the Rollins School of Public Health of Emory University. This project measures antibiotic resistance and antibiotic use in hospitals participating in CDC's National Nosocomial Infection Surveillance System (NNIS). A major goal of this study is to develop and improve mechanisms for the surveillance and control of antibiotic resistance. Some of the study's findings to date indicate that antimicrobial use and resistance are usually, but not always linked, he said.

Dr. McGowan suggested that health care systems should focus on more appropriate antimicrobial use and careful infection control practices to help combat drug-resistant bacteria in hospital settings.

Sponsors

The press conference and symposium was sponsored by NFID and was supported, in part, through unrestricted educational grants from Bayer Corporation Pharmaceutical Division, Merck Vaccine Business, Pfizer Inc., Rhône-Poulenc Rorer Inc., Roche Laboratories, Inc., SmithKline Beecham, and Zeneca Pharmaceuticals.


Herbert L. DuPont, MD, Elected as NFID's Fourth President

The National Foundation for Infectious Diseases (NFID) Board of Directors elected Herbert L. DuPont, MD, as its new president at the Board's annual meeting this past April in Washington, DC. He succeeds Leon G. Smith, MD, who served as NFID president from 1994 to 1997.

Dr. DuPont is chief of internal medicine at St. Luke's Episcopal Hospital in Houston, TX. In addition, he holds the position of Baylor College of Medicine H. Irving Schweppe, Jr., MD, chair in internal medicine. In 1973, Dr. Dupont was appointed the first director of the program in infectious diseases and clinical microbiology at The University of Texas Medical School at Houston. Since that time, he has conducted international research in many areas of infectious diseases. Dr. DuPont has also served as an epidemic intelligence service officer for the Centers for Disease Control and Prevention (CDC). An NFID director since 1981, Dr. DuPont served as an NFID vice president for the past three years.

Trustee Chairman Reelected

The Honorable Paul G. Rogers was unanimously reelected as chairman of the NFID Board of Trustees. Mr. Rogers is a former US congressman and is currently a partner with Hogan & Hartson, a law firm in Washington, DC.

Mr. Rogers has been an NFID trustee since 1988. He has received numerous accolades for his public service, including the prestigious Albert Lasker Public Service Award and NFID's 1996 Maxwell Finland Award.

"We are delighted that Paul has agreed to continue providing leadership and expertise to the Foundation," says William J. Martone, MD, NFID's senior executive director. Steven C. Tighe, first vice president at Merrill Lynch in New York, was elected by the Board of Trustees to the position of vice chairman.

New Officers

Other officers elected at the Board of Directors' April meeting included President-Elect Ronald L. Nichols, MD, William Henderson professor of surgery and professor of microbiology and immunology at Tulane University School of Medicine, and Vice President Susan J. Rehm, MD, Department of Infectious Diseases, The Cleveland Clinic Foundation.

Treasurer Robert P. Gruninger, MD, who is associate director of clinical microbiology in the Department of Pathology, Duke University School of Medicine, and Secretary H. Jean Shadomy, PhD, adjunct professor of medicine at Emory University School of Medicine, were both reelected to their current positions.


[ Previous Article ][ Table of Contents ][ Next Article ]